Manulife Financial (MFC.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Manulife Financial (MFC.TO)

57.19

+0.15 (0.26%)

as of Jun 26, 2026, 8:00:00 pm Market Open.

1634 watching

Investor Insights

Jun 26, 2026, 12:00 am

This summary was created by AI, based on 28 opinions in the last 12 months.

Manulife Financial (MFC) has garnered mixed reviews from experts, reflecting a range of perspectives on its current standing and future potential. Several analysts highlight the company's strong dividend yield and its robust performance in Asia, suggesting it may be a worthwhile long-term investment, particularly for those seeking income rather than growth. However, concerns regarding earnings fluctuations, market pullbacks, and comparisons with peers like Sun Life Financial indicate that MFC may not be as attractive as other options in the life insurance sector. Many experts recognize the potential for capital appreciation, yet they caution that the stock faces headwinds, especially when considering broader market dynamics and the performance of similar financial institutions. There is a prevailing sentiment that the stock remains a reliable choice, albeit needing careful monitoring amidst potential market corrections.

Consensus

Hold

Valuation

Fair Value

Similar

SLF

HOLD

Have been issuing a lot of stock. When you keep diluting stock and taking on more debt, it puts out more danger signals. Has some confidence in management. As interest rates go up, this company will reprice mark to market, which will mean more profits. Would like to see it under $11.50.

COMMENT

Likes long-term outlook. Operationally doing well. Significant growth opportunities in Asia, primarily Vietnam and China. Biggest challenge is liability on variable annuities and segregated funds. Will be dependent on stock market growth (which he is optimistic on) as well as long-term interest rates, which will help.

DON'T BUY

Gives you a leveraged play on equity markets and on movement in long dated treasury yields. Prefers companies that are not correlated to broad equity markets. If you have a bullish outlook on equities and feel that long dated treasuries are going to start to back up significantly, this would work positively for them.

DON'T BUY

Earnings estimates have gone down significantly with an 83% negative earnings surprise in August. Very sensitive to equity markets.

COMMENT

In the process of becoming a great buy. Getting down to Book Value and a little below. There are worries they will do another equity raise but he doesn't know that they would do this down here. Could see $2 in earnings 2 years out. He is looking to get back into this one.

WAIT

The debate in his office is when does he double up on their present holdings. Core business is fine with good expansion plans in Asia, which will eventually work well for them. This company needs higher interest rates.

COMMENT

Chances of buying back shares are very, very slim. Major concern is their capital ratio, which is still comfortably ahead of the Superintendent of Insurance mandates. This one is a play on the market. If you are positive on the market, you have to own this one.

SELL ON STRENGTH

Had a number of negative activities. His market letter indicated the stock was heading to $10 except for a minor rally that may bring it to $14. Not a stock you want to own.

DON'T BUY

Pretty close to its Fair Market Value. Gut feeling is that it could trade down to its 2008-2009 low of around $8-$8.50.

DON'T BUY

It is hurt by low interest rates. They are a leveraged play on the US stock market.

HOLD

Has probably got very oversold. Still could be some problems with their equity products. Even with write-downs, the company has a good capital base. Had a good bounce recently and he thinks that will continue. 4% yield.

STRONG BUY

Stock market hates this one but the bond market is treating it as a strong going concern. Expecting they are going to have a much better Q3 as the stock market improves. Interest rates have nowhere to go but up. Trading below book value.

BUY

There will be some tax loss selling, which will put pressure on the stock. Disclosed last quarter that not only does it have equity risk because of lack of hedging, but also have US treasury interest rate risk if rates go down. A Buy at these prices.

DON'T BUY

Hasn't owned for several years. Doesn't know if it is worth the risk at this price. Not worth chasing. Prefers Great West (GWO-T), which has a 5% yield.

SELL

Nobody knows where this company is going to go from here. Pure speculation.

Showing 1,411 to 1,425 of 2,281 entries

Most Recent Experts

Jenny Harrington, CEO, Gilman Hill Asset Management

Gilman Hill Asset Management

Stephen Weiss, Founder, Short Hills Capital Partners

Short Hills Capital Partners

Kevin Simpson

Capital Wealth Planning

Bryn Talkington

Requisite Capital Management

Andrey Omelchak

LionGuard Capital Management

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Manulife Financial (MFC.TO)